Bovine lactoferrin has a nitric oxide-dependent hypotensive effect in rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 286, Issue 2 55-2, 2004, Pages

  Hayashida, Ken Ichiro ^a   Takeuchi, Takashi ^a   Ozaki, Takeshi ^b   Shimizu, Hirohiko ^c   Ando, Kunio ^c   Miyamoto, Atsushi ^d   Harada, Etsumori ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^c Nuclear Receptor Ligand Co Ltd   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Endothelium cell; NG nitro L arginine methyl ester; Naloxone hydrochloride; Naloxone methiodide

Indexed keywords

17 METHYLNALOXONE; ACETYLCHOLINE; ATROPINE; BOVINE SERUM ALBUMIN; DICLOFENAC; GLIBENCLAMIDE; LACTOFERRIN; MORPHINE; MUSCARINIC RECEPTOR BLOCKING AGENT; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; OPIATE AGONIST; OPIATE RECEPTOR; PHENYLEPHRINE; PINACIDIL; POTASSIUM CHANNEL BLOCKING AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; CATTLE; CONTROLLED STUDY; HEART RATE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MILK; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0942265638     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00214.2003     Document Type: Article

References (46)

1. Ackley S, Barrett-Connor E, and Suarez L. Dairy products, calcium, and blood pressure. Am J Clin Nutr 38: 457-461, 1983.
2. Arnolda LF, McKitrick DJ, Llewellyn-Smith IJ, and Minson JB. Nitric oxide limits pressor responses to sympathetic activation in rat spinal cord. Hypertension 36: 1089-1092, 2000.
3. 2 secretion by breast milk macrophages. Pediatr Res 21: 54-57, 1987.
4. Baynes RD and Bezwoda WR. Lactoferrin and the inflammatory response. Adv Exp Med Biol 357: 133-141, 1994.
5. Bierenbaum ML, Wolf E, Bisgeier G, and Maginnis WP. Dietary calcium. A method of lowering blood pressure. Am J Hypertens 1: 149S-152S, 1988.
6. Brock JH. The physiology of lactoferrin. Biochem Cell Biol 80: 1-6, 2002.
7. Buonopane GJ, Kilara A, Smith JS, and McCarthy RD. Effect of skim milk supplementation on blood cholesterol concentration, blood pressure, and triglycerides id a free-living human population. J Am Coll Nutr 11: 56-67, 1992.
8. Champion HC, Bivalacqua TJ, Zadina JE, Kastin AJ, Hyman AL, and Kadowitz PJ. Role of nitric oxide in mediating vasodilator responses to opioid peptides in the rat. Clin Exp Pharmacol Physiol 29: 229-232, 2002.
9. Champion HC, Bivalacqua TJ, Zadina JE, Kastin AJ, and Kadowitz PJ. Vasodilator responses to the endomorphin peptides, but not nociceptin/OFQ, are mediated by nitric oxide release. Ann NY Acad Sci 897: 165-172, 1999.
10. 2]endomorphin 2 and endomorphin 2 have nitric oxide-dependent vasodilator activity in rats. Am J Physiol Heart Circ Physiol 274: H1690-H1697, 1998.
11. Chu X, Xu N, Li P, Mao L, and Wang JQ. Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla. Brain Res 829: 134-142, 1999.
12. Del Carmen Garcia M, Celuch SM, and Adler-Graschinsky E. Possible participation of spinal nitric oxide in the control of the blood pressure in anesthetized rats. Brain Res 764: 67-74, 1997.
13. Faucheux BA, Nillesse N, Damier P, Spik G, Mouatt-Prigent A, Pierce A, Leveugle B, Kubis N, Hauw JJ, and Agid Y. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proc Natl Acad Sci USA 92: 9603-9607, 1995.
14. Fillebeen C, Descamps L, Dehouck MP, Fenart L, Benaissa M, Spik G, Cecchelli R, and Pierce A. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem 274: 7011-7017, 1999a.
15. Fillebeen C, Mitchell V, Dexter D, Benaissa M, Beauvillain J, Spik G, and Pierce A. Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment. Brain Res Mol Brain Res 72: 183-194, 1999.
16. Fillebeen C, Ruchoux MM, Mitchell V, Vincent S, Benaissa M, and Pierce A. Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor alpha or 1-methyl-4-phenylpyridinium treatment. Brain Res Mol Brain Res 96: 103-113, 2001.
17. Garcia-Palmieri MR, Costas R Jr, Cruz-Vidal M, Sorlie PD, Tillotson J, and Havlik RJ. Milk consumption, calcium intake, and decreased hypertension in Puerto Rico Puerto Rico Heart Health Program study. Hypertension 6: 322-328, 1984.
18. 2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems. J Pharmacol Exp Ther 303: 1001-1006, 2002.
19. Hayashida K, Takeuchi T, Shimizu H, Ando K, and Harada E. Novel function of bovine milk-derived lactoferrin on antinociception mediated by μ-opioid receptor in the rat spinal cord. Brain Res 965: 239-245, 2003.
20. Hayashida K, Takeuchi T, Shimizu H, Ando K, and Harada E. Lactoferrin enhances opioid-mediated analgesia via nitric oxide in the rat spinal cord. Am J Physiol Regul Integr Comp Physiol 285: R306-R312, 2003.
21. Koga N, Takano Y, Honda K, Saito R, and Kamiya H. Roles of nitric oxide in the spinal cord in cardiovascular regulation in rats. Neurosci Lett 267: 173-176, 1999.
22. Lee SB, Koh HC, Kim ON, Sung KW, and Kim SY. Intrathecal administration of sodium nitroprusside, a nitric oxide donor, increases blood pressure in anesthetized rats. Neurosci Lett 203: 53-56, 1996.
23. Levay PF and Viljoen M. Lactoferrin: a general review. Haematologica 80: 252-267, 1995.
24. Leveugle B, Faucheux BA, Bouras C, Nillesse N, Spik G, Hirsch EC, Agid Y, and Hof PR. Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases. Acta Neuropathol (Berl) 91: 566-572, 1996.
25. Maffei FA, Heine RP, Whalen MJ, Mortimer LF, and Carcillo JA. Levels of antimicrobial molecules defensin and lactoferrin are elevated in the cerebrospinal fluid of children with meningitis. Pediatrics 103: 987-992, 1999.
26. Masson PL and Heremans JF. Lactoferrin in milk from different species. Comp Biochem Physiol B 39: 119-129, 1971.
27. Masson PL, Heremans JF, and Dive C. An iron-binding protein common to many external secretions. Clin Chim Acta 14: 735-739, 1966.
28. McCarron DA, Morris CD, Henry HJ, and Stanton JL. Blood pressure and nutrient intake in the United States. Science 224: 1392-1398, 1984.
29. Murphy ME and Brayden JE. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J Physiol 486: 47-58, 1995.
30. Norrby K, Mattsby-Baltzer I, Innocenti M, and Tuneberg S. Orally administered bovine lactoferrin systemically inhibits VEGF(165)-mediated angiogenesis in the rat. Int J Cancer 91: 236-240, 2001.
31. Obarzanek E, Velletri PA, and Cutler JA. Dietary protein and blood pressure. JAMA 275: 1598-1603, 1996.
32. Qadri F, Raqib R, Ahmed F, Rahman T, Wenneras C, Das SK, Alam NH, Mathan MM, and Svennerholm AM. Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139. Clin Diagn Lab Immunol 9: 221-229, 2002.
33. Qian ZM and Wang Q. Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Brain Res Rev 27: 257-267, 1998.
34. Reed D, McGee D, Yano K, and Hankin J. Diet, blood pressure, and multicollinearity. Hypertension 7: 405-410, 1985.
35. Sakaguchi H, Anai N, Miyamoto A, Ishiguro S, and Nishio A. Mechanisms of the enhanced contractile response to a low concentration of phorbol 12,13-dibutyrate in thoracic aorta isolated from rats with dietary magnesium deficiency. Jpn J Pharmacol 67: 9-13, 1995.
36. Sorimachi K, Akimoto K, Hattori Y, Ieiri T, and Niwa A. Activation of macrophages by lactoferrin: secretion of TNF-α, IL-8 and NO. Biochem Mol Biol Int 43: 79-87, 1997.
37. Stauss HM, Godecke A, Mrowka R, Schrader J, and Persson PB. Enhanced blood pressure variability in eNOS knockout mice. Hypertension 33: 1359-1363, 1999.
38. Stefano GB, Hartman A, Bilfinger TV, Magazine HI, Liu Y, Casares F, and Goligorsky MS. Presence of the μ3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J Biol Chem 270: 30290-30293, 1995.
39. Sun SY, Liu Z, Li P, and Ingenito AJ. Central effects of opioid agonists and naloxone on blood pressure and heart rate in normotensive and hypertensive rats. Gen Pharmacol 27: 1187-1194, 1996.
40. Takeuchi T, Hayashida K, Inagaki H, Kuwahara M, Tsubone H, Yajima T, and Harada E. Opioid mediated suppressive effect of milk-derived lactoferrin on distress induced by maternal separation in the rat pups. Brain Res 979: 216-224, 2003.
41. Talukder MJ, Takeuchi T, and Harada E. Transport of colostral macromolecules into the cerebrospinal fluid via plasma in newborn calves. J Dairy Sci 85: 514-524, 2002.
42. Teng CT. Lactoferrin gene expression and regulation: an overview. Biochem Cell Biol 80: 7-16, 2002.
43. Teschemacher H and Koch G. Opioids in the milk. Endocr Regul 25: 147-150, 1991.
44. Tsutsui M, Ueno S, Toyohira Y, and Yanagihara N. Structure and function of nitric oxide synthases [Japanese]. Tanpakushitsu Kakusan Koso 47: 2024-2031, 2002.
45. Van der Poll T, Coyle SM, Levi M, Jansen PM, Dentener M, Barbosa K, Buurman WA, Hack CE, ten Cate JW, Agosti JM, and Lowry SF. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood 89: 3727-3734, 1997.
46. Zimecki M, Miedzybrodzki R, and Szymaniec S. Oral treatment of rats with bovine lactoferrin inhibits carrageenan-induced inflammation; correlation with decreased cytokine production. Arch Immunol Ther Exp (Warsz) 46: 361-365, 1998.